NASDAQ: FLGT
Fulgent Genetics Inc Stock Forecast, Predictions & Price Target

Analyst price target for FLGT

Based on 1 analyst offering 12 month price targets for Fulgent Genetics Inc

Min Forecast
$16.00-10.71%
Avg Forecast
$16.00-10.71%
Max Forecast
$16.00-10.71%

Should I buy or sell FLGT stock?

Based on 1 analyst offering ratings for Fulgent Genetics Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Hold" rating. Learn More

Be the first to know when Wall Street analysts revise their FLGT stock forecasts and price targets.

FLGT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-04

1 of 1

Forecast return on equity

Is FLGT forecast to generate an efficient return?

Company
-4.98%
Industry
-9.77%
Market
61.99%
FLGT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is FLGT forecast to generate an efficient return on assets?

Company
-4.62%
Industry
12.56%
FLGT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FLGT earnings per share forecast

What is FLGT's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$1.88
Avg 2 year Forecast
-$1.86
Avg 3 year Forecast
-$1.83

FLGT revenue forecast

What is FLGT's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$310.5M+9.53%
Avg 2 year Forecast
$343.4M+21.14%
Avg 3 year Forecast
$375.6M+32.5%
FLGT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FLGT revenue growth forecast

How is FLGT forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
10.03%
Industry
5.28%
Market
10.68%
FLGT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FLGT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FLGT vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
FLGT$17.92$16.00-10.71%Hold
CSTL$21.14$39.60+87.32%Strong Buy
LAB$1.19$2.50+110.08%Strong Buy
MYGN$7.40$18.35+147.97%Buy
PSNL$3.16$8.00+153.16%Strong Buy

Fulgent Genetics Stock Forecast FAQ

Is Fulgent Genetics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: FLGT) stock is to Hold FLGT stock.

Out of 1 analyst, 0 (0%) are recommending FLGT as a Strong Buy, 0 (0%) are recommending FLGT as a Buy, 1 (100%) are recommending FLGT as a Hold, 0 (0%) are recommending FLGT as a Sell, and 0 (0%) are recommending FLGT as a Strong Sell.

If you're new to stock investing, here's how to buy Fulgent Genetics stock.

What is FLGT's earnings growth forecast for 2025-2027?

(NASDAQ: FLGT) Fulgent Genetics's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 29.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.64%.

Fulgent Genetics's earnings in 2025 is -$42,708,000.On average, 2 Wall Street analysts forecast FLGT's earnings for 2025 to be -$57,959,374, with the lowest FLGT earnings forecast at -$58,575,963, and the highest FLGT earnings forecast at -$57,342,784. On average, 2 Wall Street analysts forecast FLGT's earnings for 2026 to be -$57,188,637, with the lowest FLGT earnings forecast at -$57,959,374, and the highest FLGT earnings forecast at -$56,417,901.

In 2027, FLGT is forecast to generate -$56,417,901 in earnings, with the lowest earnings forecast at -$56,417,901 and the highest earnings forecast at -$56,417,901.

What is FLGT's revenue growth forecast for 2025-2027?

(NASDAQ: FLGT) Fulgent Genetics's forecast annual revenue growth rate of 10.03% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.

Fulgent Genetics's revenue in 2025 is $283,470,000.On average, 2 Wall Street analysts forecast FLGT's revenue for 2025 to be $9,572,237,172, with the lowest FLGT revenue forecast at $9,557,130,740, and the highest FLGT revenue forecast at $9,587,343,605. On average, 2 Wall Street analysts forecast FLGT's revenue for 2026 to be $10,586,526,209, with the lowest FLGT revenue forecast at $10,515,926,759, and the highest FLGT revenue forecast at $10,657,125,659.

In 2027, FLGT is forecast to generate $11,579,542,922 in revenue, with the lowest revenue forecast at $11,579,542,922 and the highest revenue forecast at $11,579,542,922.

What is FLGT's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: FLGT) forecast ROA is -4.62%, which is lower than the forecast US Diagnostics & Research industry average of 12.56%.

What is FLGT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year FLGT price target, the average FLGT price target is $16.00, with the highest FLGT stock price forecast at $16.00 and the lowest FLGT stock price forecast at $16.00.

The Wall Street analyst predicted that Fulgent Genetics's share price could fall to $16.00 by Mar 4, 2026. The average Fulgent Genetics stock price prediction forecasts a potential downside of 10.71% from the current FLGT share price of $17.92.

What is FLGT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: FLGT) Fulgent Genetics's current Earnings Per Share (EPS) is -$1.41. On average, analysts forecast that FLGT's EPS will be -$1.88 for 2025, with the lowest EPS forecast at -$1.90, and the highest EPS forecast at -$1.86. On average, analysts forecast that FLGT's EPS will be -$1.86 for 2026, with the lowest EPS forecast at -$1.88, and the highest EPS forecast at -$1.83. In 2027, FLGT's EPS is forecast to hit -$1.83 (min: -$1.83, max: -$1.83).

What is FLGT's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: FLGT) forecast ROE is -4.98%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.